Spyre Therapeutics (SYRE) Assets (2015 - 2026)
Spyre Therapeutics' Assets came in at $1.17 billion for Q2 2026, up 117.7% from $538.83 million a year earlier and up 53.5% from the prior quarter.
Powered by 
Analysis
Spyre Therapeutics (SYRE) Assets (2015 - 2026) Analysis & Trends
At the end of FY2025, Spyre Therapeutics' Assets was $777.78 million, up 27.8% from FY2024.
- Assets has increased in each of the last three years, with a five-year compound annual growth rate of 36.9% (FY2020 to FY2025).
- Going back by year, Assets was $608.48 million in FY2024 (+78.0%), $341.86 million in FY2023 (+380.5%), $71.14 million in FY2022 (-35.3%) and $109.93 million in FY2021 (-32.0%).
- The Q2 2026 figure represents the highest quarterly Assets in data going back to Q4 2015.
- Year-over-year, Assets has increased for 13 consecutive quarters, with growth averaging 52.6% over the last eight quarters.
- The fastest year-over-year change in Assets over five years came in Q1 2024 (growth of 829.6%), and the weakest in Q1 2022 (a decline of 49.2%).
- Business Quant data shows SYRE's Assets at $763.95 million (Q1 2026), $777.78 million (Q4 2025) and $504.6 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Spyre Therapeutics | 7.46 Bn | 7.46 Bn | - | 1.17 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.17 Bn |
| Mar 31, 2026 | 763.95 Mn |
| Dec 31, 2025 | 777.78 Mn |
| Sep 30, 2025 | 504.60 Mn |
| Jun 30, 2025 | 538.83 Mn |
| Mar 31, 2025 | 569.78 Mn |
| Dec 31, 2024 | 608.48 Mn |
| Sep 30, 2024 | 421.09 Mn |
| Jun 30, 2024 | 436.07 Mn |
| Mar 31, 2024 | 487.60 Mn |
| Dec 31, 2023 | 341.86 Mn |
| Sep 30, 2023 | 207.27 Mn |
| Jun 30, 2023 | 243.53 Mn |
| Mar 31, 2023 | 52.45 Mn |
| Dec 31, 2022 | 71.14 Mn |
| Sep 30, 2022 | 91.57 Mn |
| Jun 30, 2022 | 106.71 Mn |
| Mar 31, 2022 | 83.17 Mn |
| Dec 31, 2021 | 109.93 Mn |
| Sep 30, 2021 | 129.06 Mn |
API Access
Spyre Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=SYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "SYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=SYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();